Detection and Spread of Escherichia coli Possessing the Plasmid-Borne Carbapenemase KPC-2 in Brooklyn, New York

This publication has 24 references indexed in Scilit:

• Plasmid-Mediated Imipenem-Hydrolyzing Enzyme KPC-2 among Multiple Carbapenem-Resistant Escherichia coli Clones in Israel
  Antimicrobial Agents and Chemotherapy, 2006
• First Detection of the Plasmid-Mediated Class A Carbapenemase KPC-2 in Clinical Isolates of Klebsiella pneumoniae from South America
  Antimicrobial Agents and Chemotherapy, 2006
• A new screening method for carbapenem-resistant Acinetobacter baumanii and Pseudomonas aeruginosa
  Journal of Hospital Infection, 2005
• Escherichia coli: Development of Carbapenem Resistance During Therapy
  Clinical Infectious Diseases, 2005
• Detection of KPC Carbapenem-Hydrolyzing Enzymes in Enterobacter spp. from Brooklyn, New York
  Antimicrobial Agents and Chemotherapy, 2005
• In Vivo Acquisition of High-Level Resistance to Imipenem inEscherichia coli
  Journal of Clinical Microbiology, 2004
• Emergence of Carbapenem-Resistant Klebsiella Species Possessing the Class A Carbapenem-Hydrolyzing KPC-2 and Inhibitor-Resistant TEM-30 -Lactamases in New York City
  Clinical Infectious Diseases, 2004
• Extended-Spectrum β-Lactamases in Klebsiella pneumoniae Bloodstream Isolates from Seven Countries: Dominance and Widespread Prevalence of SHV- and CTX-M-Type β-Lactamases
  Antimicrobial Agents and Chemotherapy, 2003
• Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Acinetobacter baumannii Endemic in New York City
  Clinical Infectious Diseases, 2003
• Escherichia coli with a Self-Transferable, Multiresistant Plasmid Coding for Metallo-β-Lactamase VIM-1
  Antimicrobial Agents and Chemotherapy, 2003